Survey of Selenium and lipids plasma levels in hemodialysis patients (Short Report)

Yahya Pasdar; Hamid Reza  Omrani; Dariyush  Raeisi; Masoud Ahmadi; Afshin  Almasi; Mehrangiz  Soleimani; Kambiz  Jasemi

Journal of Clinical Research in Paramedical Sciences

The Official Journal of Paramedical School, KUMS

Current Issue Archive In Press Accepted Manuscripts Search

Journal Information Boards and Committees Indexing and Listing Sources Open Peer Review (OPR)Journal Metrics Publication Ethics and Publication Malpractice Statement Reviewer and AE Registration Form Support Contact Us

Authors Guide Submit Manuscript

Survey of Selenium and lipids plasma levels in hemodialysis patients (Short Report)

Author(s):

Yahya Pasdar¹,

Hamid Reza Omrani²,

Dariyush Raeisi²,

Masoud Ahmadi³,

Afshin Almasi⁴,

Mehrangiz Soleimani³,

Kambiz Jasemi^2,*

1Department of Nutritional Sciences, School of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran

2Department of Internal Medicine, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran

3Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran

4Department of Biostatics and Epidemiology, School of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran

Journal of Clinical Research in Paramedical Sciences:Vol. 3, issue 4; e83586

Published online:Feb 26, 2015

Article type:Brief Report

Received:Jul 26, 2014

Accepted:Jan 27, 2015

How to Cite:Pasdar Y, Omrani H R, Raeisi D, Ahmadi M, Almasi A, et al. Survey of Selenium and lipids plasma levels in hemodialysis patients (Short Report).J Clin Res Paramed Sci.2015;3(4):e83586.

Abstract

One of the most important side effects in hemodialysis patients is cardiovascular diseases. Selenium has an important role in reducing of atherosclerosis due to participation in structure of anti-oxidant enzymes. This study was to determine serum levels of selenium and plasma lipids in hemodialysis patients who referred to Imam Reza hospital. In this study we measured serum level of selenium, triglyceride, cholesterol, high density lipoprotein (HDL) and low density lipoprotein (LDL). Serum level of selenium in patients was significantly lower than control group (P<0.01). Also, serum level of LDL, triglyceride and cholesterol in patients was significantly higher than control group (P<0.01). The results of this study can develop this hypothesis that selenium as a medicine can reduce rate of cardiovascular diseases in hemodialysis patients.

Keywords

Selenium

Hemodialysis

Lipid

Fulltext

The full text of this article is available on PDF.

References

1.
The References of this article is available on PDF.

comments